Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening

This publication has 26 references indexed in Scilit:

• Body mass index does not improve the ability to predict biochemical recurrence after radical prostatectomy
  European Journal Of Cancer, 2007
• Effects of obesity and height on prostate‐specific antigen (PSA) and percentage of free PSA levels among African‐American and Caucasian men
  Cancer, 2006
• Prevalence of Overweight and Obesity in the United States, 1999-2004
  JAMA, 2006
• Obesity, Serum Prostate Specific Antigen and Prostate Size: Implications for Prostate Cancer Detection
  Journal of Urology, 2006
• Associations of demographic and lifestyle characteristics with prostate‐specific antigen (PSA) concentration and rate of PSA increase
  Cancer, 2005
• Body mass index is weakly associated with, and not a helpful predictor of, disease progression in men with clinically localized prostate carcinoma treated with radical prostatectomy
  Cancer, 2005
• The association of body mass index and prostate‐specific antigen in a population‐based study
  Cancer, 2005
• Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults
  New England Journal of Medicine, 2003
• Prostate Cancer in Relation to Diet, Physical Activity, and Body Size in Blacks, Whites, and Asians in the United States and Canada
  JNCI Journal of the National Cancer Institute, 1995
• Physical activity and the risk of prostate and testicular cancer: a cohort study of 53,000 Norwegian men
  Cancer Causes & Control, 1994